Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Billionaire John Paulson is reportedly set to reap $500 million from Amgen's huge deal to acquire Horizon Therapeutics
02:55pm, Monday, 12'th Dec 2022
Horizon is the largest disclosed holding of John Paulson's family office Paulson & Co., according to Forbes.
Horizon Therapeutics Acquisition: A Good Deal For Amgen Investors
02:35pm, Monday, 12'th Dec 2022
Amgen is acquiring Horizon Therapeutics for $27.8 billion. The deal immediately adds $3.7 billion in annual revenue.
Amgen to acquire Horizon Therapeutics for $27.8 billion
01:53pm, Monday, 12'th Dec 2022
Yahoo Finance's Anjalee Khemlani explains news of a major biotech merger as Amgen is set to acquire Horizon Therapeutics.
These 2 Nasdaq Stocks Are Soaring on Merger News
01:48pm, Monday, 12'th Dec 2022 The Motley Fool
Find out which companies are attracting interest from prospective buyers.
Retail capitulation may be a new year's gift for the stock market, says this analyst
01:46pm, Monday, 12'th Dec 2022 MarketWatch
Retail investors are skittish about this market, and understandably. Our call of the day says that may only help lure back influential investors in the new year.
Amgen (AMGN) to Buy Horizon Therapeutics For $27.8 Billion
01:32pm, Monday, 12'th Dec 2022
Amgen (AMGN) wins the race to buy Horizon Therapeutics and makes an acquisition offer of $27.8 billion.
Reuters
Broadcom's Vmware Draws More Regulatory Attention, This Time From EU
U.S. chipmaker Broadcom Inc's (NASDAQ: AVGO) $61 billion Vmware, Inc (NYSE: VMW) deal could hit a roadblock
Take the Zacks Approach to Beat the Market: NVIDIA, Boeing, Amgen in Focus
01:05pm, Monday, 12'th Dec 2022 Zacks Investment Research
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Big Week to Set Tone for Markets Amid Investor, Fed Worries
12:45pm, Monday, 12'th Dec 2022 Investing.comWhat Amgen Is Getting Through The Acquisition Of Horizon Therapeutics
12:44pm, Monday, 12'th Dec 2022
Amgen Inc. will acquire Horizon Therapeutics Public Limited Company for $116.50 per share in an all-cash transaction. This is a suboptimal exit for Horizon shareholders, but we should acknowledge the
First Test for Amgen: Fix Horizon's Growth Problem
12:10pm, Monday, 12'th Dec 2022
Sales of Horizon's thyroid-eye disease drug Tepezza have plateaued, a challenge its new owner will need to contend with.
Busy Week Highlighted by Next Fed Rate Move
12:02pm, Monday, 12'th Dec 2022
Consensus is currently for a 50 basis point (bps) hike mid-week, which will bring the Fed funds rate over +4% for the first time in 15 years.
Wall Street Awaits Key Fed FOMC Decision
12:02pm, Monday, 12'th Dec 2022
Wall Street Awaits Key Fed FOMC Decision
Billionaire John Paulson Stands To Make $500 Million From Horizon's Sale To Amgen
11:40am, Monday, 12'th Dec 2022
Hedge fund billionaire John Paulson stands to reap about $500 million if Amgen's deal for Horizon goes through. It's the latest victory for the man who shot to fame for his big bet during the subprime
Amgen to buy Horizon Therapeutics for $26.4B
10:45am, Monday, 12'th Dec 2022
Amgen Inc. announced on Monday that it will acquire Horizon Therapeutics for $26 billion to further grow the company's medical legacy. Horizon's best-selling drug is Tepezza.
